Mack Gill

Mack Gill

Director/Board Member at ALTIMMUNE, INC.

Net worth: 19 951 $ as of 29/04/2024

72 year
Health Technology
Technology Services
Consumer Services

Profile

John M.
Gill
founded TetraLogic Pharmaceuticals Corp.
in 2001, where he worked as Director from 2013 to 2014.
Dr. Gill also currently works at Millennium Information Technologies Ltd., as Chief Executive Officer from 2013, Altimmune, Inc., as Independent Director from 2004, and Torstone Technology Ltd., as Chief Operating Officer.
Dr. Gill also formerly worked at PharmAthene, Inc., as President, Chief Executive Officer & Director from 2015 to 2017, 3-Dimensional Pharmaceuticals, Inc., as Chief Financial Officer, Director & Executive VP, PharmAthene, Inc., as Director in 2007, Theraclone Sciences, Inc., as Director, The Biotechnology Greenhouse Corp.
of Southeastern PA, as Director, Ben Franklin Technology Partners, as Director, FIS Capital Markets US LLC (Pennsylvania), as SVP-Corporate Development & Strategy, GSK Equity Investments Ltd., as President, US Department of Defense (District of Columbia), as Principal from 1971 to 1973, Smithkline & French Laboratories US, Inc., as Chief Operating Officer, SunGard Financial Systems, as President-Global Technology, Nova Pharmaceutical Corp., as Chief Operating Officer, GlaxoSmithKline LLC, as VP-Research & Development Operations, and Sungard Global Services France SA, as President in 2011.
Dr. Gill received his undergraduate degree in 1975 from Rutgers State University of New Jersey, graduate degree from Yale University, and undergraduate degree from the University of British Columbia.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
21/03/2024 2,771 ( 0.00% ) 19 951 $ 29/04/2024

Mack Gill active positions

CompaniesPositionStart
ALTIMMUNE, INC. Director/Board Member 31/07/2004
Chief Executive Officer 22/05/2013
Chief Operating Officer -
All active positions of Mack Gill

Former positions of Mack Gill

CompaniesPositionEnd
Chief Executive Officer 30/04/2017
TETRALOGIC PHARMACEUTICALS CORPORATION Founder 28/01/2014
President 28/02/2011
Director/Board Member 29/04/2008
Director/Board Member 02/08/2007
See the detail of Mack Gill's experience

Training of Mack Gill

Rutgers State University of New Jersey Undergraduate Degree
University of British Columbia Undergraduate Degree
Yale University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mack Gill's experience

Connections

100 +

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
TETRALOGIC PHARMACEUTICALS CORPORATION

Health Technology

ALTIMMUNE, INC.

Health Technology

Private companies16

Finance

US Department of Defense (District of Columbia)

Government

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Technology Services

Technology Services

Technology Services

Technology Services

Commercial Services

Smithkline & French Laboratories US, Inc.

Nova Pharmaceutical Corp.

Technology Services

See company connections